ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 609699 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 609699; 2) Community: the network communities that were significantly associated with the response to NSC 609699; 3) Molecule: the relationships between components within communities and NSC 609699; 4) MDR: the compounds that were significantly associated with the NSC 609699.

NSC Compound Enrichment Correlation
NSC 634724 10,11-methylenedioxycamptothecin 0.000395532514722381 0.89089408
NSC 683555 Camptothecin Derivative 0.000395532514722381 0.8630157
NSC 648265 [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin 0.000574000735425498 -0.057062336
NSC 693543 4-Acridinecarboxamide, 9-amino-N-[3-[(2-aminoethyl)amino]propyl]-5-methyl-, trihydrochloride 0.000871592241209852 0.30985867
NSC 107124 Camptothecin Derivative 0.000871592241209859 0.93069135
NSC 364830 Camptothecin Derivative 0.000871592241209859 0.91889489
NSC 292147 12-Hydroxyindolo[2,1-b]quinazoline-6(12H)-one 0.00112942993514739 0.11916124
NSC 146067 cis-Diamminemalonatoplatinum(II) 0.00115358042961468 0.36860033
NSC 651861 Null 0.00115358042961469 0.56996552
NSC 681634 Camptothecin Derivative 0.00115358042961469 0.91602122
Total:51  Current:2    [First] [Prev] [Next] [Last]